1. Nebeker JR, Barach P, Samore MH (2004) Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 140(10):795–801
2. (1995) Clinical safety data management: definitions and standards for expedited reporting. London: European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit.
www.emea.eu.int/pdfs/human/ich/037795en.pdf
. Accessed 16 Dec 2003
3. O’Brien, Charles P (2001) Chapt 24 Drug Addiction and Drug Abuse. In: Hardman JG and Limbird, LE (eds.) Goodman and Gilman’s the pharmacological basis of therapeutics, 10th edn. McGraw-hill, pp 621-642
4. O’Brien, Charles P (2001) Chapt 24 Drug Addiction and Drug Abuse. In: Hardman JG and Limbird, LE (eds.) Goodman and Gilman’s the pharmacological basis of therapeutics, 10th edn. McGraw-hill, p 624
5. Rizzoli P, Loder E (2011) Tolerance to the beneficial effects of prophylactic migraine drugs: a systematic review of causes and mechanisms. Headache 51:1323–1335